Academic Radiology, ISSN 1076-6332, 2014, Volume 21, Issue 2, pp. 232 - 249
The technology behind positron emission tomography (PET) and the most widely used tracer, 2-deoxy-2-[18F]fluoro-D-glucose (FDG), were both conceived in the...
Radiology | FDG | 2-deoxy-2-[18F]fluoro-D-glucose | molecular imaging | Positron emission tomography/computed tomography | PET/CT | Molecular imaging | RHEUMATOID-ARTHRITIS | ATHEROSCLEROTIC PLAQUE INFLAMMATION | UNDERLYING MALIGNANCY | ALZHEIMERS-DISEASE | HIBERNATING MYOCARDIUM | F-18 FLUORODEOXYGLUCOSE UPTAKE | IMAGING TECHNIQUES | POSITRON-EMISSION-TOMOGRAPHY | VASCULAR INFLAMMATION | DUAL-TIME-POINT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Fluorodeoxyglucose F18 - pharmacokinetics | Radiopharmaceuticals - pharmacokinetics | Humans | Multimodal Imaging - methods | Tomography, X-Ray Computed - methods | Molecular Imaging - methods | Positron-Emission Tomography - methods | Glucose metabolism | Glucose | PET imaging | Tracers (Biology) | Dextrose
Radiology | FDG | 2-deoxy-2-[18F]fluoro-D-glucose | molecular imaging | Positron emission tomography/computed tomography | PET/CT | Molecular imaging | RHEUMATOID-ARTHRITIS | ATHEROSCLEROTIC PLAQUE INFLAMMATION | UNDERLYING MALIGNANCY | ALZHEIMERS-DISEASE | HIBERNATING MYOCARDIUM | F-18 FLUORODEOXYGLUCOSE UPTAKE | IMAGING TECHNIQUES | POSITRON-EMISSION-TOMOGRAPHY | VASCULAR INFLAMMATION | DUAL-TIME-POINT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Fluorodeoxyglucose F18 - pharmacokinetics | Radiopharmaceuticals - pharmacokinetics | Humans | Multimodal Imaging - methods | Tomography, X-Ray Computed - methods | Molecular Imaging - methods | Positron-Emission Tomography - methods | Glucose metabolism | Glucose | PET imaging | Tracers (Biology) | Dextrose
Journal Article
American Journal of Roentgenology, ISSN 0361-803X, 08/2011, Volume 197, Issue 2, pp. 284 - 294
OBJECTIVE. This article will discuss the F-18-FDG normal variant uptake and the role of FDG PET/CT in malignancies in HIV-infected patients, CNS manifestations...
HIV | FDG PET/CT | HUMAN-IMMUNODEFICIENCY-VIRUS | MULTICENTRIC CASTLEMANS-DISEASE | F-18 FLUORODEOXYGLUCOSE | NERVOUS-SYSTEM LESIONS | POSITRON-EMISSION-TOMOGRAPHY | KAPOSIS-SARCOMA | ACTIVE ANTIRETROVIRAL THERAPY | INFECTED PATIENTS | AIDS-RELATED MALIGNANCIES | SEROPOSITIVE SUBJECTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Fluorodeoxyglucose F18 - pharmacokinetics | Neoplasms - etiology | Radiopharmaceuticals - pharmacokinetics | Humans | Tomography, X-Ray Computed - methods | Positron-Emission Tomography - methods | Neoplasms - diagnostic imaging | Disease Progression | Antiretroviral Therapy, Highly Active | Central Nervous System - diagnostic imaging | Fever of Unknown Origin - diagnostic imaging | Fever of Unknown Origin - etiology | HIV Infections - complications | HIV Infections - drug therapy
HIV | FDG PET/CT | HUMAN-IMMUNODEFICIENCY-VIRUS | MULTICENTRIC CASTLEMANS-DISEASE | F-18 FLUORODEOXYGLUCOSE | NERVOUS-SYSTEM LESIONS | POSITRON-EMISSION-TOMOGRAPHY | KAPOSIS-SARCOMA | ACTIVE ANTIRETROVIRAL THERAPY | INFECTED PATIENTS | AIDS-RELATED MALIGNANCIES | SEROPOSITIVE SUBJECTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Fluorodeoxyglucose F18 - pharmacokinetics | Neoplasms - etiology | Radiopharmaceuticals - pharmacokinetics | Humans | Tomography, X-Ray Computed - methods | Positron-Emission Tomography - methods | Neoplasms - diagnostic imaging | Disease Progression | Antiretroviral Therapy, Highly Active | Central Nervous System - diagnostic imaging | Fever of Unknown Origin - diagnostic imaging | Fever of Unknown Origin - etiology | HIV Infections - complications | HIV Infections - drug therapy
Journal Article
American Journal of Roentgenology, ISSN 0361-803X, 09/2010, Volume 195, Issue 3, pp. 737 - 743
OBJECTIVE. The purpose of this article is to review FDG PET/CT and MRI findings in a variety of benign and malignant tumors of the uterus and to become...
Oncologic imaging | Uterus | FDG PET/CT | Uterine tumors | MRI | SURVIVAL | CERVICAL-CANCER | LEIOMYOMAS | F-18 FLUORODEOXYGLUCOSE | uterus | POSITRON-EMISSION-TOMOGRAPHY | LYMPH-NODE METASTASIS | uterine tumors | oncologic imaging | ENDOMETRIAL | STANDARDIZED UPTAKE VALUE | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Precancerous Conditions - diagnostic imaging | Magnetic Resonance Imaging | Endometrial Neoplasms - diagnostic imaging | Uterine Neoplasms - diagnostic imaging | Humans | Leiomyoma - diagnostic imaging | Tomography, X-Ray Computed - methods | Female | Fluorodeoxyglucose F18 | Sarcoma - diagnostic imaging | Positron-Emission Tomography - methods | Radiopharmaceuticals
Oncologic imaging | Uterus | FDG PET/CT | Uterine tumors | MRI | SURVIVAL | CERVICAL-CANCER | LEIOMYOMAS | F-18 FLUORODEOXYGLUCOSE | uterus | POSITRON-EMISSION-TOMOGRAPHY | LYMPH-NODE METASTASIS | uterine tumors | oncologic imaging | ENDOMETRIAL | STANDARDIZED UPTAKE VALUE | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Precancerous Conditions - diagnostic imaging | Magnetic Resonance Imaging | Endometrial Neoplasms - diagnostic imaging | Uterine Neoplasms - diagnostic imaging | Humans | Leiomyoma - diagnostic imaging | Tomography, X-Ray Computed - methods | Female | Fluorodeoxyglucose F18 | Sarcoma - diagnostic imaging | Positron-Emission Tomography - methods | Radiopharmaceuticals
Journal Article
Radiographics, ISSN 0271-5333, 01/2010, Volume 30, Issue 1, pp. 269 - 291
The term extranodal disease refers to lymphomatous infiltration of anatomic sites other than the lymph nodes. Almost any organ can be affected by lymphoma,...
B-CELL LYMPHOMA | POSITRON-EMISSION-TOMOGRAPHY | F-18 FLUORODEOXYGLUCOSE PET/CT | MALIGNANT-LYMPHOMA | RESPONSE ASSESSMENT | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | BROWN ADIPOSE-TISSUE | T-CELL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CLINICAL-SIGNIFICANCE | Humans | Middle Aged | Hodgkin Disease - diagnosis | Tomography, X-Ray Computed - methods | Male | Positron-Emission Tomography - methods | Subtraction Technique | Young Adult | Adult | Female | Fluorodeoxyglucose F18 | Radiopharmaceuticals | Lymph Nodes - diagnostic imaging | Lymphoma, Non-Hodgkin - diagnosis
B-CELL LYMPHOMA | POSITRON-EMISSION-TOMOGRAPHY | F-18 FLUORODEOXYGLUCOSE PET/CT | MALIGNANT-LYMPHOMA | RESPONSE ASSESSMENT | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | BROWN ADIPOSE-TISSUE | T-CELL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CLINICAL-SIGNIFICANCE | Humans | Middle Aged | Hodgkin Disease - diagnosis | Tomography, X-Ray Computed - methods | Male | Positron-Emission Tomography - methods | Subtraction Technique | Young Adult | Adult | Female | Fluorodeoxyglucose F18 | Radiopharmaceuticals | Lymph Nodes - diagnostic imaging | Lymphoma, Non-Hodgkin - diagnosis
Journal Article
5.
Full Text
Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT: A case report
Medicine (United States), ISSN 0025-7974, 11/2017, Volume 96, Issue 46, p. e8471
Rationale: F-18 Fluoro Deoxyglucose positron emission tomography and computed tomography (F-18 FDG PET/CT) is a useful modality in the evaluation of patients...
F-18 FDG PET/CT | Metabolic superscan | Renal osteodystrophy | MEDICINE, GENERAL & INTERNAL | metabolic superscan | renal osteodystrophy | Chronic Kidney Disease-Mineral and Bone Disorder - diagnostic imaging | Positron Emission Tomography Computed Tomography | Adult | Fluorodeoxyglucose F18 | Male | Humans
F-18 FDG PET/CT | Metabolic superscan | Renal osteodystrophy | MEDICINE, GENERAL & INTERNAL | metabolic superscan | renal osteodystrophy | Chronic Kidney Disease-Mineral and Bone Disorder - diagnostic imaging | Positron Emission Tomography Computed Tomography | Adult | Fluorodeoxyglucose F18 | Male | Humans
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 10/2015, Volume 42, Issue 11, pp. 1666 - 1673
To determine if the histology of a breast malignancy influences the appearance of untreated osseous metastases on FDG PET/CT.This retrospective study was...
Medicine & Public Health | Ductal | Orthopedics | PET/CT | Lobular | Oncology | Breast cancer | Nuclear Medicine | Imaging / Radiology | Cardiology | Osseous metastases | THERAPY | YIELD | EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | F-18 FLUORODEOXYGLUCOSE | LOBULAR CARCINOMA | Bone Neoplasms - diagnosis | Bone Neoplasms - diagnostic imaging | Humans | Middle Aged | Bone Neoplasms - secondary | Tomography, X-Ray Computed | Positron-Emission Tomography | Multimodal Imaging | Neoplasm Grading | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Female | Fluorodeoxyglucose F18 | Aged | Retrospective Studies | PET imaging | Metastasis | lobular | osseous metastases | breast cancer | ductal | PET
Medicine & Public Health | Ductal | Orthopedics | PET/CT | Lobular | Oncology | Breast cancer | Nuclear Medicine | Imaging / Radiology | Cardiology | Osseous metastases | THERAPY | YIELD | EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | F-18 FLUORODEOXYGLUCOSE | LOBULAR CARCINOMA | Bone Neoplasms - diagnosis | Bone Neoplasms - diagnostic imaging | Humans | Middle Aged | Bone Neoplasms - secondary | Tomography, X-Ray Computed | Positron-Emission Tomography | Multimodal Imaging | Neoplasm Grading | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Female | Fluorodeoxyglucose F18 | Aged | Retrospective Studies | PET imaging | Metastasis | lobular | osseous metastases | breast cancer | ductal | PET
Journal Article
European Journal of Radiology, ISSN 0720-048X, 2014, Volume 83, Issue 7, pp. 1169 - 1176
Abstract Objective To determine the associations of quantitative parameters derived from multiphase contrast-enhanced magnetic resonance imaging (CE-MRI),...
Radiology | Quantitative parameters | MRI | Survival | Cervical cancer | DWI | PET/CT | VOLUME | CHEMORADIOTHERAPY | APPARENT DIFFUSION-COEFFICIENT | F-18 FLUORODEOXYGLUCOSE | POSITRON-EMISSION-TOMOGRAPHY | DISEASE | COMBINED CHEMORADIATION | RECURRENCE | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Reproducibility of Results | Prognosis | Uterine Cervical Neoplasms - diagnosis | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Tomography, X-Ray Computed - methods | Survival Rate | Positron-Emission Tomography - methods | Biomarkers, Tumor | Young Adult | Sensitivity and Specificity | Multimodal Imaging - methods | Adult | Female | Fluorodeoxyglucose F18 | Aged | Retrospective Studies | Radiopharmaceuticals | Cancer patients | Care and treatment | PET imaging | Magnetic resonance imaging | Nuclear radiation | Radiology, Medical | Glucose metabolism | Medical research | Medicine, Experimental | Metastasis | Biological markers
Radiology | Quantitative parameters | MRI | Survival | Cervical cancer | DWI | PET/CT | VOLUME | CHEMORADIOTHERAPY | APPARENT DIFFUSION-COEFFICIENT | F-18 FLUORODEOXYGLUCOSE | POSITRON-EMISSION-TOMOGRAPHY | DISEASE | COMBINED CHEMORADIATION | RECURRENCE | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Reproducibility of Results | Prognosis | Uterine Cervical Neoplasms - diagnosis | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Tomography, X-Ray Computed - methods | Survival Rate | Positron-Emission Tomography - methods | Biomarkers, Tumor | Young Adult | Sensitivity and Specificity | Multimodal Imaging - methods | Adult | Female | Fluorodeoxyglucose F18 | Aged | Retrospective Studies | Radiopharmaceuticals | Cancer patients | Care and treatment | PET imaging | Magnetic resonance imaging | Nuclear radiation | Radiology, Medical | Glucose metabolism | Medical research | Medicine, Experimental | Metastasis | Biological markers
Journal Article
Hepato-Gastroenterology, ISSN 0172-6390, 05/2010, Volume 57, Issue 99-100, pp. 447 - 450
Background/Aims: This study aimed to evaluate the clinical utility in Fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET)/computed tomography...
FDG-PET | Steroid | Autoimmune pancreatitis | Pancreatic cancer | SURGERY | PROPOSAL | CANCER | F-18 FLUORODEOXYGLUCOSE | LESIONS | POSITRON-EMISSION-TOMOGRAPHY | DISEASE | DIFFERENTIATION | ACCUMULATION | GASTROENTEROLOGY & HEPATOLOGY | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Autoimmune Diseases - diagnosis | Pancreatitis - drug therapy | Positron-Emission Tomography - methods | Adrenal Cortex Hormones - therapeutic use | Pancreatitis - diagnosis | Female | Fluorodeoxyglucose F18 | Radiopharmaceuticals | Autoimmune Diseases - drug therapy
FDG-PET | Steroid | Autoimmune pancreatitis | Pancreatic cancer | SURGERY | PROPOSAL | CANCER | F-18 FLUORODEOXYGLUCOSE | LESIONS | POSITRON-EMISSION-TOMOGRAPHY | DISEASE | DIFFERENTIATION | ACCUMULATION | GASTROENTEROLOGY & HEPATOLOGY | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Autoimmune Diseases - diagnosis | Pancreatitis - drug therapy | Positron-Emission Tomography - methods | Adrenal Cortex Hormones - therapeutic use | Pancreatitis - diagnosis | Female | Fluorodeoxyglucose F18 | Radiopharmaceuticals | Autoimmune Diseases - drug therapy
Journal Article
AMERICAN JOURNAL OF ROENTGENOLOGY, ISSN 0361-803X, 11/2019, Volume 213, Issue 5, pp. 1129 - 1135
OBJECTIVE. The aim of this study was to assess the diagnostic performance of dual-phase F-18-FDG PET/CT in detecting axillary lymph node metastasis in patients...
TOMOGRAPHY | DIAGNOSIS | F-18-FDG PET/CT | breast neoplasms | TIME | PARAMETERS | CYTOLOGY | RETENTION INDEX | FINE-NEEDLE-ASPIRATION | ULTRASOUND | DISSECTION | F-18 FDG | lymphatic metastasis | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET
TOMOGRAPHY | DIAGNOSIS | F-18-FDG PET/CT | breast neoplasms | TIME | PARAMETERS | CYTOLOGY | RETENTION INDEX | FINE-NEEDLE-ASPIRATION | ULTRASOUND | DISSECTION | F-18 FDG | lymphatic metastasis | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET
Journal Article
Cancer Imaging, ISSN 1470-7330, 08/2016, Volume 16, Issue 1
Pheochromocytomas (PCC) and paragangliomas (PGL) are neuroendocrine tumours arising from pluripotent neural crest stem cells and are associated with neurons of...
Paraganglioma | Pheochromocytoma | F-18 FDG | Ga-68 DOTATATE | PET/CT | Chromaffin cells | Usage | Research | Radiopharmaceuticals
Paraganglioma | Pheochromocytoma | F-18 FDG | Ga-68 DOTATATE | PET/CT | Chromaffin cells | Usage | Research | Radiopharmaceuticals
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 4, pp. e439 - e445
Purpose Accurate delineation of target volumes is important to maximize radiation dose to the tumor and minimize it to nontumor tissue. Computed tomography...
Radiology | Hematology, Oncology and Palliative Medicine | Locally advanced rectal cancer | Computed tomography | Radiotherapy | Gross tumor volume | 18F fluorodeoxyglucose positron emission tomography | Delineation | F fluorodeoxyglucose positron emission tomography | TOMOGRAPHY | DEFINITION | F-18 fluorodeoxyglucose positron emission tomography | GUIDED RADIOTHERAPY | MANAGEMENT | CHEMORADIOTHERAPY | CELL LUNG-CANCER | IMPACT | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | SEGMENTATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prospective Studies | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Positron-Emission Tomography | Tumor Burden | Rectal Neoplasms - radiotherapy | Rectal Neoplasms - diagnostic imaging | Magnetic Resonance Imaging | Multimodal Imaging | Sweden | Aged, 80 and over | Adult | Female | Fluorodeoxyglucose F18 | Aged | Rectal Neoplasms - pathology | Radiopharmaceuticals | Care and treatment | Oncology, Experimental | Radiation | Tomography | Diagnostic imaging | Research | Cancer | Tumors | PATIENTS | NEOPLASMS | RECTUM | METASTASES | FLUORODEOXYGLUCOSE | RADIATION DOSES | CAT SCANNING | PLANNING | NMR IMAGING | POSITRON COMPUTED TOMOGRAPHY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | FLUORINE 18 | Medical and Health Sciences | Medicin och hälsovetenskap
Radiology | Hematology, Oncology and Palliative Medicine | Locally advanced rectal cancer | Computed tomography | Radiotherapy | Gross tumor volume | 18F fluorodeoxyglucose positron emission tomography | Delineation | F fluorodeoxyglucose positron emission tomography | TOMOGRAPHY | DEFINITION | F-18 fluorodeoxyglucose positron emission tomography | GUIDED RADIOTHERAPY | MANAGEMENT | CHEMORADIOTHERAPY | CELL LUNG-CANCER | IMPACT | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | SEGMENTATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prospective Studies | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Positron-Emission Tomography | Tumor Burden | Rectal Neoplasms - radiotherapy | Rectal Neoplasms - diagnostic imaging | Magnetic Resonance Imaging | Multimodal Imaging | Sweden | Aged, 80 and over | Adult | Female | Fluorodeoxyglucose F18 | Aged | Rectal Neoplasms - pathology | Radiopharmaceuticals | Care and treatment | Oncology, Experimental | Radiation | Tomography | Diagnostic imaging | Research | Cancer | Tumors | PATIENTS | NEOPLASMS | RECTUM | METASTASES | FLUORODEOXYGLUCOSE | RADIATION DOSES | CAT SCANNING | PLANNING | NMR IMAGING | POSITRON COMPUTED TOMOGRAPHY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | FLUORINE 18 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 07/2018, Volume 45, Issue 7, pp. 1250 - 1269
Large vessel vasculitis (LVV) is defined as a disease mainly affecting the large arteries, with two major variants. Takayasu arteritis (TA) and giant cell...
Large vessel vasculitis | Imaging procedure | Polymyalgia rheumatica | FDG-PET/CT(A) | EARLY-DIAGNOSIS | TAKAYASU ARTERITIS | FOLLOW-UP | DISEASE-ACTIVITY | F-18 FDG-PET/CT | POSITRON-EMISSION-TOMOGRAPHY | ABATACEPT CTLA-4IG | DOUBLE-BLIND TRIAL | WALL INFLAMMATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | GIANT-CELL ARTERITIS | Positron Emission Tomography Computed Tomography | Giant Cell Arteritis - diagnostic imaging | Public Opinion | Humans | Fluorodeoxyglucose F18 | Polymyalgia Rheumatica - diagnostic imaging | Positron-Emission Tomography | Nuclear medicine | Damage assessment | Angiography | Disease | Standardization | Committees | Positron emission | Arteries | Inflammatory diseases | Arteritis | Medicine | Vasculitis | Computed tomography | Imaging | Tomography | Diagnosis | Cardiology
Large vessel vasculitis | Imaging procedure | Polymyalgia rheumatica | FDG-PET/CT(A) | EARLY-DIAGNOSIS | TAKAYASU ARTERITIS | FOLLOW-UP | DISEASE-ACTIVITY | F-18 FDG-PET/CT | POSITRON-EMISSION-TOMOGRAPHY | ABATACEPT CTLA-4IG | DOUBLE-BLIND TRIAL | WALL INFLAMMATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | GIANT-CELL ARTERITIS | Positron Emission Tomography Computed Tomography | Giant Cell Arteritis - diagnostic imaging | Public Opinion | Humans | Fluorodeoxyglucose F18 | Polymyalgia Rheumatica - diagnostic imaging | Positron-Emission Tomography | Nuclear medicine | Damage assessment | Angiography | Disease | Standardization | Committees | Positron emission | Arteries | Inflammatory diseases | Arteritis | Medicine | Vasculitis | Computed tomography | Imaging | Tomography | Diagnosis | Cardiology
Journal Article
MOLECULAR IMAGING AND BIOLOGY, ISSN 1536-1632, 04/2012, Volume 14, Issue 2, pp. 252 - 259
Technetium (Tc) methylene diphosphonate (MDP) has been the standard method for bone scintigraphy for three decades. F-18 sodium fluoride (F-18 NaF) positron...
SCANS | Malignancy | F-18 NaF | F-18-FLUORIDE PET/CT | SPECT | LESIONS | PLANAR BONE-SCINTIGRAPHY | FLUORIDE | BREAST-CANCER | POSITRON-EMISSION-TOMOGRAPHY | Tc-99m MDP | PET/CT | PROSTATE-CANCER | F-18 FDG | DIAGNOSED LUNG-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
SCANS | Malignancy | F-18 NaF | F-18-FLUORIDE PET/CT | SPECT | LESIONS | PLANAR BONE-SCINTIGRAPHY | FLUORIDE | BREAST-CANCER | POSITRON-EMISSION-TOMOGRAPHY | Tc-99m MDP | PET/CT | PROSTATE-CANCER | F-18 FDG | DIAGNOSED LUNG-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
14.
Full Text
The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer
Molecular Imaging and Biology, ISSN 1536-1632, 2/2019, Volume 21, Issue 1, pp. 1 - 10
The applications of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/X-ray computed tomography (PET/CT) in the management of patients with breast...
Breast neoplasms | Medicine & Public Health | Imaging / Radiology | [ 18 F]FDG | Positron emission tomography/computed tomography | computed tomography | F-18-FDG PET/CT | PROGNOSTIC-FACTORS | EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY | PATHOLOGICAL RESPONSE | [F-18]FDG | COMPUTED-TOMOGRAPHY | LYMPH-NODE METASTASES | 18F-FDG PET/CT | NEOADJUVANT CHEMOTHERAPY | PREOPERATIVE PET/CT | STANDARDIZED UPTAKE VALUE | Positron emission tomography | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Positron Emission Tomography Computed Tomography - trends | Prognosis | Humans | Lymphatic Metastasis | Neoplasm Recurrence, Local - diagnosis | Neoplasm Staging - trends | Breast Neoplasms - therapy | Neoplasm Recurrence, Local - pathology | Neoplasm Staging - methods | Breast Neoplasms - pathology | Sensitivity and Specificity | Female | Fluorodeoxyglucose F18 | Breast Neoplasms - diagnosis | Positron Emission Tomography Computed Tomography - methods | CT imaging | Chemotherapy | PET imaging | Imaging systems | Breast cancer | Diagnosis | Metastasis | Glucose | Drug therapy | Dextrose | Cancer | Tumor markers | Positron emission | Acetylcysteine | Scintigraphy | Medical diagnosis | Patients | Metastases | Computed tomography | Biopsy | Tomography | Breast | Diagnostic systems | Bone | Bone imaging
Breast neoplasms | Medicine & Public Health | Imaging / Radiology | [ 18 F]FDG | Positron emission tomography/computed tomography | computed tomography | F-18-FDG PET/CT | PROGNOSTIC-FACTORS | EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY | PATHOLOGICAL RESPONSE | [F-18]FDG | COMPUTED-TOMOGRAPHY | LYMPH-NODE METASTASES | 18F-FDG PET/CT | NEOADJUVANT CHEMOTHERAPY | PREOPERATIVE PET/CT | STANDARDIZED UPTAKE VALUE | Positron emission tomography | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Positron Emission Tomography Computed Tomography - trends | Prognosis | Humans | Lymphatic Metastasis | Neoplasm Recurrence, Local - diagnosis | Neoplasm Staging - trends | Breast Neoplasms - therapy | Neoplasm Recurrence, Local - pathology | Neoplasm Staging - methods | Breast Neoplasms - pathology | Sensitivity and Specificity | Female | Fluorodeoxyglucose F18 | Breast Neoplasms - diagnosis | Positron Emission Tomography Computed Tomography - methods | CT imaging | Chemotherapy | PET imaging | Imaging systems | Breast cancer | Diagnosis | Metastasis | Glucose | Drug therapy | Dextrose | Cancer | Tumor markers | Positron emission | Acetylcysteine | Scintigraphy | Medical diagnosis | Patients | Metastases | Computed tomography | Biopsy | Tomography | Breast | Diagnostic systems | Bone | Bone imaging
Journal Article
MEDICINE, ISSN 0025-7974, 04/2018, Volume 97, Issue 17, p. e0098
To assess the diagnostic accuracy of CA125, its kinetic values and positron emission tomography/computed tomography with 2-deoxy-2-[F-18]fluoro-d-glucose...
kinetic parameters | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | PROGNOSTIC-FACTOR | ovarian cancer recurrence | EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY | PET/CT | CA125 | [F-18]FDG-PET | CHEMOTHERAPY | CA-125 Antigen - blood | Early Detection of Cancer - methods | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - diagnosis | Biomarkers, Tumor | Female | Fluorodeoxyglucose F18 | ROC Curve | Aged | Retrospective Studies | Positron Emission Tomography Computed Tomography - methods
kinetic parameters | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | PROGNOSTIC-FACTOR | ovarian cancer recurrence | EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY | PET/CT | CA125 | [F-18]FDG-PET | CHEMOTHERAPY | CA-125 Antigen - blood | Early Detection of Cancer - methods | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - diagnosis | Biomarkers, Tumor | Female | Fluorodeoxyglucose F18 | ROC Curve | Aged | Retrospective Studies | Positron Emission Tomography Computed Tomography - methods
Journal Article
Medicine, ISSN 0025-7974, 04/2018, Volume 97, Issue 16, p. e0389
Background: Gastrointestinal stromal tumor (GIST) is a rare cancer in gastrointestinal carcinomas and has been widely known as a curable disease among all the...
REVIEWS | MEDICINE, GENERAL & INTERNAL | GIST | MRI | PERFORMANCE | specificity | gastrointestinal stromal tumors | RECURRENCE | sensitivity | network meta-analysis | CLINICAL MANAGEMENT | F-18 FDG PET | Reproducibility of Results | Early Detection of Cancer - methods | Humans | Magnetic Resonance Imaging - methods | Tomography, X-Ray Computed - methods | Gastrointestinal Neoplasms - diagnosis | Positron-Emission Tomography - methods | Gastrointestinal Neoplasms - pathology | Gastrointestinal Stromal Tumors - diagnosis | Gastrointestinal Stromal Tumors - pathology | Fluorodeoxyglucose F18 - pharmacology | Radiopharmaceuticals - pharmacology | Research Design
REVIEWS | MEDICINE, GENERAL & INTERNAL | GIST | MRI | PERFORMANCE | specificity | gastrointestinal stromal tumors | RECURRENCE | sensitivity | network meta-analysis | CLINICAL MANAGEMENT | F-18 FDG PET | Reproducibility of Results | Early Detection of Cancer - methods | Humans | Magnetic Resonance Imaging - methods | Tomography, X-Ray Computed - methods | Gastrointestinal Neoplasms - diagnosis | Positron-Emission Tomography - methods | Gastrointestinal Neoplasms - pathology | Gastrointestinal Stromal Tumors - diagnosis | Gastrointestinal Stromal Tumors - pathology | Fluorodeoxyglucose F18 - pharmacology | Radiopharmaceuticals - pharmacology | Research Design
Journal Article